Because previous studies have shown that a high molecular mass constituent of cranberry juice inhibited adhesion of Escherichia coli to epithelial cells and coaggregation of oral bacteria, we have examined its effect on the adhesion of Helicobacter pylori to immobilized human mucus and to erythrocytes. We employed three strains of H. pylori all of which bound to the mucus and agglutinated human erythrocytes via a sialic acid-specific adhesin. The results showed that a high molecular mass constituent derived from cranberry juice inhibits the sialic acid-specific adhesion of H. pylori to human gastric mucus and to human erythrocytes. ß
Introduction
Since the discovery in the early 80s implicating Helicobacter pylori as the major cause for a variety of gastrointestinal diseases including gastric, duodenal and peptic ulcers, as well as gastric cancer, numerous studies have focused on the virulence factors of this pathogen [1^4] . Asymptomatic carriage of H. pylori by about half of the population is the major source of infection in humans. It has been suggested that the best way to prevent H. pylori infections is to eliminate the pathogen from its most common habitat, the gastric mucus layer [5] . To cause ulcer and other gastric diseases, the organism must leave the mucus layer and adhere to the underlying epithelium. At least ¢ve di¡erent adhesins have been described that mediate adhesion of the pathogen to epithelial cells and in some cases to erythrocytes [6] . They include adhesins speci¢c for sialic acid, the Lewis a and Lewis b antigens and sulfated glycosaminoglycans. It has been suggested that the ability of H. pylori to express various combinations of adhesins with distinct receptor speci¢city determines whether it will attach to the epithelium or remains in the mucus [2] . Adhesion to epithelial cells has been recognized as an essential step of the infectious process for virtually all bacterial pathogens and therefore much e¡orts are aimed to develop anti-adhesion therapy for bacterial infections [7] . It has indeed been reported that sialyllactose (NeuAc(K2-3)Gal(L1-4)Glc), an inhibitor of the sialic acidspeci¢c adhesin of H. pylori, reduced signi¢cantly the load of the bacteria in monkeys [8] . The majority of the H. pylori population resides in the mucus which binds the organisms via speci¢c interactions [6, 9, 10] . Thus, it would seem appropriate to target such therapy against H. pylori toward its association with the mucus before the pathogen adheres to the underlying epithelial cells and causes disease.
Tzouvelakis et al. [10] established the method to study adhesion of H. pylori to gastric mucus and Wadstrom et al. [6] found that this adhesion may be mediated by the sialic acid-speci¢c adhesin. Other enteropathogens are also capable of binding to mucus constituents via speci¢c adhesins. For example Escherichia coli adheres to 45 and 50 kDa glycoproteins in human mucus via its mannose-spe-ci¢c ¢mbriae [11] . Although oligosaccharides speci¢c for the H. pylori lectins may potentially act as inhibitors of adhesion to mucus, their production in commercial amounts as anti-adhesion therapeutic agents is still a problem. As an alternative approach it has been suggested that dietary inhibitors may be the solution for certain infections [7] . Cranberry juice has been studied for some time for its bacterial anti-adhesive properties and has been found to inhibit adhesion of E. coli in vitro [12, 13] . Moreover, daily consumption of cranberry juice has been shown to reduce urinary tract infections caused by E. coli in humans [14] . A high molecular mass constituent isolated from cranberry was found to act as inhibitor not only of uropathogenic E. coli but of coaggregation of certain oral bacteria as well [15, 16] . In a recent report proanthocyanidin extracts from cranberries were shown to inhibit the adhesion of P-¢mbriated E. coli to uroepithelial cells [17] .
In the present study it will be demonstrated that under the growth conditions employed, the adhesion of three strains of H. pylori to human gastric mucus and erythrocytes is mediated by the sialic acid-speci¢c adhesin of the bacteria and is inhibited by a high molecular mass constituent derived from cranberry juice.
Materials and methods

Materials
Non-dialyzable material (NDM) was prepared as previously described [12] . Brie£y, cranberry juice was dialyzed against distilled water in dialysis bags with a cuto¡ point of molecular mass 12 000^15 000 at 4³C for 6 days and the NDM was lyophilized. The digoxigenin labeled Sambucus nigra agglutinin (SNA), a lectin speci¢c for sialic acid, anti-digoxigenin and bromophenol blue substrate were purchased from Roche Ltd., Mannheim, Germany. Extracellular matrix material from the bovine eye was obtained as described [18] . Twin 20, glucose, galactose, mannose, fucose, lactose, sialic acid were from Sigma Chemical Co. (St. Louis, MO, USA) and 3P-sialyllactose was obtained from Megafarm-Calbiochem. Solutions of the two latter compounds were adjusted to pH 7 with 0.5 N NaOH.
Bacterial strains and culture conditions
Two clinical isolates of H. pylori (BZMC-25 and EHL-65) were obtained from the Gastroenterology Department, Bnei-Zion Medical Center and from the Ezra Health Laboratory, Haifa, Israel. One strain 17874 was a gift from Dr. Sussan Teneberg, Medical Centre, Orebro, Sweden. All of the strains are cagA (cytotoxin-associated gene) and vacA (vacuolating cytotoxin) positive. Primary isolation was performed on selective egg yolk emulsion (EYE) agar [19] . Brie£y, the EYE contained (% w/v): 4.1% Columbia agar base (Oxoid, CM 331), 0.2% yeast extract, 10% EYE, tetrazolium chloride (Sigma Chemical Co., St. Louis, MO, USA), 0.004% and H. pylori selective supplement (Dent, Oxoid, CR 147). Following primary selective isolation, H. pylori were identi¢ed according to colony morphology, Gram staining, microaerophilic growth (at 37³C), oxidase+, catalase+, urease+, and by the polymerase chain reaction [20, 21] .
Growth of H. pylori was maintained under microaerophilic conditions in anaerobic jars with CampyPakPlus (BBL, Beckton Dickinson Microbiology Systems, Cockeysville, MD, USA) at 37³C for 2^5 days on EYE agar or in Brain Heart Infusion Broth (Difco, East Molesey, UK) containing 10% (v/v) fetal calf serum (Biological Industry, Kibbutz Beit-Haemek, Israel) and H. pylori selective supplement (Dent, Oxoid) for 1^3 days. Bacterial isolates were stored as described previously [22] . The morphology of bacteria changed according to growth conditions and age: while until 2 days of growth the bacteria were predominantly rod-like, at 2^3 days of growth the morphology of the bacteria was mixed, with both coccoid and rod forms, and over 4 days of growth more than 95% of bacterial cells were coccoid. After growth of H. pylori on agar plates or in liquid medium for the required growth period, the bacteria were harvested, washed and suspended in sterilized phosphate-bu¡ered saline (PBS : 20 mM PO 4 , saline 0.85%, pH 6.8). In order to determine the number of colony forming units (CFU) appropriate aliquots of the bacterial suspension were spread on agar plates and after a growth period of 3 days colonies were counted. The turbidity of the suspension was adjusted to 0.3 OD (optical density) at 660 nm (ca. 2.4U10 8 þ 3U10 7 CFU ml 31 ) and used for the experiments at the same day.
Preparation of mucus-coated microtiter wells
The gastric mucus was from human stomachs taken after post-mortem surgeries from the pathological laboratories in Rambam Meical Center, Haifa, Israel, and partially puri¢ed as previously described [23] . Brie£y, 10% (v/ v) of the crude mucus in 0.1 M NaCl was adjusted to pH 7 with NaOH and stirred overnight at 4³C. Insoluble material was removed by centrifugation at 8000Ug for 10 min and the dissolved mucus was precipitated by adding ethanol to a ¢nal concentration of 60% (v/v). The precipitate was pelleted by centrifugation, as before, then lyophilized and kept at 320³C. For binding studies the mucus was dissolved (150 Wg ml 31 ) in carbonate^bicarbonate bu¡er, (20 mM, pH 9.6) and 100 Wl of the mucus suspension was dispensed into wells of a polystyrene microplate (Dynathech, McLean, VA, USA). The mucus was allowed to dry on the bottom of the wells by incubation overnight at 37³C. After three washes of unbound material with PBS, the mucus-coated wells were blocked with 10 mg ml 31 of bovine serum albumin (Sigma) for 90 min at room temperature with continuous shaking (100 rpm).
Mucus treatments
Sialidase (neuraminidase): mucus was desialylated by adding 50 mU ml 31 of Vibrio cholerae sialidase (Sigma) to 2.4 mg ml 31 of mucus in PBS containing 1 mM Ca 2 , pH 5.5. After incubation for 1 h at 37³C, the mixture was chilled on ice for 5 min and then centrifuged for 10 min at 12 000Ug to remove insoluble material [24] . The asialomucus was lyophilized and kept in 320³C. Removal of sialic acid was con¢rmed by the assay of sialic acid-speci¢c lectin binding to the treated mucus following the manufacturer's instructions.
Sodium metaperiodate: sodium metaperiodate (100 Wl, 10 mM) was added to the mucus-coated wells and incubated for 1 h at 37³C. The wells were then washed three times with PBS, blocked by incubation with bovine serum albumin (10 mg ml 31 ) overnight at 4³C and used in the adhesion assay [25] .
Determination of bacteria bound to mucus 2.5.1. By the urease test
A 100-Wl suspension of H. pylori at the desired density was added to each mucus-coated well. After 90 min incubation at 37³C, the wells were washed with PBS to remove unbound bacteria. To estimate the number of bound bacteria, 100 Wl of urea reagents solution consisting of 2.5 ml PBS (3 mM, pH 6.8), 0.4 ml urea solution (2% in PBS, 330 Wmol l 31 ) and 0.1 ml phenol red (7 Wg ml 31 , pH 5.0) was added to each well [22] . The color development was monitored at 560 nm with enzyme-linked immunosorbent assay (ELISA) reader MR-5000 at 37³C every 30 min for 2 h. To convert the absorbance readings into CFU ml 31 , a standard curve was constructed as follows : to 5 Wl of serial 2-fold dilutions of known amounts of bacteria (typically from 10 4 to 10 6 ) in each microtiter well, 95 Wl of the urease reagents solution was added. The microtiter plate was incubated for 90 min at 37³C, and the absorbancy at 560 nm was then recorded. The absorbancy of urease in control wells consisting of 95 Wl urea reagents solution and 5 Wl PBS was subtracted from all values to obtain net absorbancy as an indicator of bacterial urease activity. Each determination was performed in quadruplicates.
Inhibition of bacterial binding was performed by preincubation of the bacteria with di¡erent concentrations of the test compounds for 30 min at 37³C after which the mixture was added to mucus-coated wells. The percent inhibition was calculated by the following equation: % inhibition = no. of treated bacteria bound/no. of nontreated bacteria boundU100 or no. of bacteria bound to treated mucus/no. of bacteria bound to untreated mucusU100.
2.5.2.. By ELISA
To mucus-coated wells containing bound bacteria as described above, 35 Wl of rabbit anti-H. pylori antiserum (Virostat, Portland, ME, USA) diluted to 1/5000 in antibody bu¡er (PBS+twin 20, 0.05%) was added. Following incubation for 90 min at 37³C the wells were washed ¢ve times with washing solution (NaCl 0.15 M+twin 20, 0.05%) and 100 Wl of horseradish peroxidase-labeled anti-rabbit immunoglobulin-G (Sigma) diluted 1/2500 in antibody bu¡er was added to each well. After further incubation for 90 min at 37³C, the wells were washed ¢ve times as above, 150 Wl substrate solution (one tablet of Ophenylenediamine (Sigma)/12 ml citrate-phosphate bu¡er+ H 2 O 2 , 0.03%, pH 5) was added to each well. The color was allowed to develop for 10^20 min at 37³C and then 50 Wl of 4 N H 2 SO 4 was added to stop the reaction. The OD was recorded at 490 nm with ELISA reader MR-5000. Controls consisted of wells without bacteria [26] .
Hemagglutination assay
Equal volumes of 2-fold dilutions of H. pylori cell suspensions and 5% suspensions of human red blood cells (RBC) (25 Wl) type O were mixed in wells of microtiter plates (U-shaped) and allowed to settle at room temperature for 1^2 h. Hemagglutination was visualized by the aggregated cells setting on the bottom of the well forming a loose carpet [27, 28] .
Hemagglutination inhibition assay
Bacterial suspensions were diluted with PBS to give ++++ HAU (4-hemagglutination units). Inhibition tests were performed by mixing 25 Wl bacterial suspension with 25 Wl of di¡erent concentrations of inhibitor for 30 min at room temperature, after which 25 Wl of a 5% RBC suspension was added to each well and allowed to settle at room temperature for 1^2 h.
Results
Binding characteristics of H. pylori to human gastric mucus
To estimate the binding of H. pylori to human gastric mucus in the solid phase assay standard curves were constructed for each bacterial suspension employed in the particular experiment relating the level of urease activity to the number of bacteria (CFU ml 31 ) . Typical examples are shown in Fig. 1A ,B. The urease activity of the bound bacteria reached plateau in most of the experiments after 2 h incubation (data not shown) and adhesion was highest for bacteria harvested after 2 days culture in broth. Urease activity was low being 0.0212, 0.03 and 0.016 OD for H. pylori remaining bound to bovine submaxillary glands mucin, gastric porcine mucin, and bovine extracellular matrix, respectively, as compared to 0.1865 OD for bacteria bound to human gastric mucin.
E¡ect of NDM on adhesion of H. pylori
NDM at 100 Wg ml 31 concentrations inhibited markedly the adhesion of H. pylori BZMC-25 to human gastric mucus ( Fig. 2A) . This inhibition was noted when the adhesion of the bound bacteria was monitored by urease activity assay or by ELISA using anti-H. pylori antiserum ruling out the possibility that the inhibition is con¢ned to urease-active bacteria. In separate experiments we found that 100 Wg ml 31 NDM did not a¡ect the urease activity of H. pylori (data not shown). The inhibition of adhesion by NDM is dose dependent and the 50% inhibitory concentration is strain dependent being 37, 125 and 305 Wg ml 31 of NDM for H. pylori strains BZMC-25, EHL-65 and 17874, respectively (Fig. 2B) .
The adhesion of strains BZMC-25 and 17874 was not a¡ected when the mucus was ¢rst treated with NDM nor when the NDM was added after the bacteria were allowed to adhere to the mucus (Fig. 3A,C) . It was, however, abrogated when the mucus was pretreated with sodium metaperiodate, which oxidizes vicinal hydroxyl groups in carbohydrate residues, and with sialidase, which removes terminal non-reducing sialic acid residues. Con¢rmation that the latter treatment removed the bulk of the sialic acid was obtained by the use of SNA lectin: the sialidase-treated mucus bound only 20% of the lectin, as compared to the untreated mucus. Adhesion of H. pylori strains to mucus was inhibited speci¢cally by 3P-sialyllactose, but not by lactose or three other simple sugars tested (Fig. 3B,D) . In separate experiments we found that 6-sialyllactose was without e¡ect (data not shown).
H. pylori is known to cause hemagglutination of human erythrocytes either via its sialic acid-speci¢c adhesin or via its ability to bind to the Lewis b antigen [9, 28] . NDM inhibited in a dose dependent fashion the hemagglutination of human erythrocytes caused by strains 25 and 17874 ( Table 1 ). The hemagglutination was sensitive to sialyllactose but resistant to inhibition by Lewis antigen or acetyl lactosamine, suggesting that it is mediated by the sialic acid-speci¢c adhesin of the bacteria employed.
Discussion
The adhesion of H. pylori to mucus constituents in the human stomach is a prerequisite for the colonization of this unique niche, which has become the major habitat of the pathogen on this planet [5, 9] . While a number of speci¢c adhesins and their cognate receptors on human cell membrane have been identi¢ed [29^33] little is known on the speci¢city of H. pylori adhesion to human gastric mucus. We employed the urease activity of bacteria bound to immobilized mucus used by other investigators to measure bacterial adhesion [10] . This adhesion is human-speci¢c because the bacteria did not adhere to bovine extracellular matrix nor to porcine gastric mucus. Furthermore, the adhesion of the H. pylori strains used to human gastric mucus is abrogated by periodate oxidation or desialylation of the mucus and is inhibited speci¢cally by sialyllactose but not by lactose or various monosaccharides. This sialic acid-speci¢c adhesion is best expressed by bacteria grown in broth for 48 h. Our results con¢rm those obtained by others showing that H. pylori binds to sialic acid glycoconjugates in human gastric mucus via its sialic acid adhesin [10, 34] . They are also consistent with previous ¢nd-ings showing that gastric mucus inhibited sialic acidspeci¢c adhesion of H. pylori to epithelial cell lines [35, 36] . Human gastric mucus, however, may contain sulfated glycoconjugates which act as inhibitors of adhesion of H. pylori to epithelial cells [34, 37] . In preliminary studies we found that sulfated sugars (e.g. heparin) did not inhibit adhesion of H. pylori strain BZMC-25 to human mucus, suggesting that this carbohydrate is not involved in the adhesion system employed.
Our data show that the sialic acid-speci¢c adhesion to human gastric mucus and to erythrocytes is inhibited by NDM constituents derived from cranberry. The 50% inhibitory concentration of NDM was 37, 125 and 305 Wg ml 31 of NDM for H. pylori strains BZMC-25, EHL-65 and 17874, respectively. Selective inhibition of bacterial adhesion by NDM was noted in previous studies. Thus, NDM inhibited adhesion of P-¢mbriated E. coli to erythrocytes but not of type 1 ¢mbriated E. coli nor of diarheogenic E. coli [15] . It also inhibited the coaggregation of certain but not all oral bacterial pairs [16] . In all these cases the target for the NDM action is the bacteria and this is also the case for H. pylori because preincubation of NDM with mucus has no e¡ect on adhesion of this organism. NDM at 100 Wg ml 31 did not cause detachment of the bacteria from mucus. It is well known that detachment of bacteria is di¤cult to achieve. For example, sialyllactose detached less than 10% of bacteria bound to epithelial cell monolayer preexposed to 5U10 7 CFU per ml density [35] .
It has been argued that the most common habitat of H. pylori is gastric mucus and to cause a disease, generations 31 ) (N1) or with 10 mM sodium metaperiodate (P), washed free of the reagent followed by adding the bacteria to estimate adhesion, untreated mucus served as control (N0). In another system (N2) the bacteria were ¢rst allowed to adhere and then NDM (200 Wg ml 31 ) was added followed by washing to estimate adhesion. In B and D the adhesion to mucus of bacteria suspended in bu¡er containing NDM (200 Wg ml 31 ) (N), sialyllactose (4.3 mM) (S), and D-galactose (G), D-mannose (M), L-fucose (F) and lactose (L), each at 100 mM concentration, was determined and expressed as percent of control containing bu¡er alone. Adhesion was determined by monitoring the urease activity of adherent bacteria as described in the text. The values of the mean of at least four experiments as percent of the control are shown with standard deviations. Asterisks represent signi¢cant (P 6 0.01) reduction in adhesion as compared to the control. of H. pylori must detach from mucus and reach the underlying epithelium [9] . Cranberry juice may inhibit such de novo adhesion by virtue of its NDM constituent. Previous clinical trials have shown that consumption of cranberry over a de¢ned period of time may prevent recurrent urinary tract infections probably by inhibiting the adhesion of uropathogens to intestinal cells, the source of uropathogens [14, 15] . Similarly, consumption of cranberry over a de¢ned period may inhibit the sialic acid-speci¢c adhesion of H. pylori to new sites either in the mucus or on the epithelium and may form a possible therapeutic approach.
